Business Description
Sandoz Group AG
ISIN : US7999261008
Share Class Description:
SDZNY: ADRCompare
Compare
Traded in other countries / regions
SDZ.SwitzerlandSDZz.UKSDZNY.USAD8Y0.Germany IPO Date
2023-10-04Description
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as the first US biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate | 92.9 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.32 | |||||
| 9-Day RSI | 62.73 | |||||
| 14-Day RSI | 61.05 | |||||
| 6-1 Month Momentum % | 9.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward Dividend Yield % | 1.5 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| Forward PE Ratio | 11.58 | |||||
| PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
| EV-to-EBIT | -565299.6 | |||||
| EV-to-Forward-EBIT | 16.18 | |||||
| EV-to-EBITDA | -565299.6 | |||||
| EV-to-Forward-EBITDA | 10.03 | |||||
| EV-to-Forward-Revenue | 1.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SDZNY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sandoz Group AG Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 61.05 | ||
| 14-Day ATR ($) | 0.745632 | ||
| 20-Day SMA ($) | 30.61195 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 25.71 - 34.94 | ||
| Shares Outstanding (Mil) | 431 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sandoz Group AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sandoz Group AG Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sandoz Group AG Frequently Asked Questions
What is Sandoz Group AG(SDZNY)'s stock price today?
The current price of SDZNY is $32.80. The 52 week high of SDZNY is $34.94 and 52 week low is $25.71.
When is next earnings date of Sandoz Group AG(SDZNY)?
The next earnings date of Sandoz Group AG(SDZNY) is 2024-06-28 Est..
Does Sandoz Group AG(SDZNY) pay dividends? If so, how much?
Sandoz Group AG(SDZNY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers